Employing αGalCer-loaded CD1d-tetramers, we observed that frequencies of iNKT cells in PBMC from new-MS patients and HD were similar, while they were significantly lower in new-MS CSF (Figure 1D). The gene discussed is CD1D; the disease is myeloid sarcoma.